The global intraoperative imaging market size was valued at USD 3.73 billion in 2025 and is projected to grow from USD 3.97 billion in 2026 to USD 6.69 billion by 2034, registering a CAGR of 6.74% during the forecast period (2026–2034). North America dominated the intraoperative imaging marketwith a marketshare of 35.11% in 2025.
Intraoperative imaging refers to advanced imaging systems used during surgical procedures to provide real time visualization of anatomical structures, enabling surgeons to improve precision and clinical decision making. These systems include intraoperative MRI, CT, ultrasound, fluoroscopy, and other imaging technologies used across neurosurgery, orthopedic, cardiovascular, spinal, and oncology procedures. They support accurate surgical navigation and allow immediate assessment of surgical outcomes.
The intraoperative imaging market demand is increasing due to the rising number of complex surgeries, growing adoption of minimally invasive procedures, and continuous advancements in imaging technologies. Increasing healthcare investments and focus on precision-guided surgery are further driving intraoperative imaging market growth.
Download a Free Sample to Explore Detailed Market Insights
The intraoperative imaging market is sensitive to supply chain disruptions due to its reliance on advanced imaging components, semiconductor chips, precision sensors, and globally sourced electronic assemblies. Disruptions in the supply chain have delayed equipment manufacturing, extended installation timelines, and increased procurement costs for healthcare providers across multiple regions. These challenges have also affected the availability of replacement parts and service support, influencing hospital purchasing decisions and slowing the adoption of new intraoperative imaging systems worldwide. The market is demonstrating a capacity-constrained recovery, supported by improving component availability, localized manufacturing initiatives, and increasing investments in resilient supply chain networks.
Healthcare providers are increasingly adopting artificial intelligence enabled intraoperative imaging platforms that combine real-time imaging with surgical navigation and decision support. This transition is improving surgical precision, enhancing workflow efficiency, and enabling better visualization during complex procedures. AI assisted image processing and automated anatomical recognition are helping surgeons make faster and more accurate intraoperative decisions across neurosurgery, orthopedic, and spine surgeries.
Hospitals are increasingly adopting hybrid operating rooms equipped with advanced intraoperative imaging to support complex and minimally invasive surgeries. This shift is improving surgical precision, enabling real-time treatment verification, and reducing revision procedures across neurosurgery, cardiovascular, and orthopedic interventions. For example, intraoperative cone beam CT allows surgeons to confirm spinal implant placement and vascular treatment outcomes during surgery, improving procedural accuracy and patient safety.
The interoperative imaging market forecasts sustained investments driven by e growing demand for AI-enabled image-guided surgery platforms, hybrid operating rooms, and advanced real-time visualization technologies that improve surgical precision. Increasing funding for innovative surgical imaging companies and continued hospital investments in minimally invasive and integrated imaging solutions are expected to accelerate product development and global commercialization.
Key Investment and Funding Activities in Intraoperative Imaging Market, 2026
Hypervision Surgical
≈USD 23 Million
In April 2026, Hypervision Surgical completed an oversubscribed Series A financing round led by Heal Capital with participation from Angelini Ventures, IP Group, Daycrest, ZEISS Ventures, Redalpine, LifeX Ventures, HERAN Partners, SAGES Ingenuity, and Macmillan Cancer Support.
Illuminant Surgical
USD 8.4 Million
In April 2026, Illuminant Surgical raised USD 8.4 million in Seed funding led by Wing 2 Wing Ventures, with participation from the US National Science Foundation (NSF), National Cancer Institute (NCI), National Institute on Aging (NIA), Elderberry Ventures, Soma Capital, and others.
XEOS
USD 15.2 Million
In January 2026, XEOS secured funding to expand commercialization of its AURA 10, the world's first intraoperative specimen PET-CT system, across Europe and the United States while strengthening clinical evidence.
Rising Need to Reduce Surgical Revisions & Reoperations and Growing Emphasis on Value-based Healthcare Drives Market
The growing emphasis on reducing surgical revisions is driving demand for intraoperative imaging systems that enable surgeons to assess procedural outcomes before completing an operation. Real-time imaging improves surgical accuracy, helping hospitals lower complication rates, avoid repeat interventions, and optimize operating room efficiency. This demand is particularly strong in neurosurgery and oncology, where complete lesion removal is critical for long-term patient outcomes. For example, The University of Texas MD Anderson Cancer Center utilizes intraoperative MRI during brain tumor surgery to detect residual tumor tissue during the procedure, allowing additional resection in the same operation and reducing the need for subsequent surgeries while improving the extent of tumor removal.
The growing emphasis on value-based healthcare is driving demand for intraoperative imaging systems that improve surgical accuracy, reduce complications, and shorten hospital stays. Healthcare providers are increasingly investing in technologies that enhance clinical outcomes while lowering the overall cost of care through fewer postoperative interventions. As reimbursement models become more outcome oriented, hospitals are prioritizing image-guided surgical platforms that support decision making.
High Capital Investment and Inconsistent Reimbursement Restrain Market Expansion
The high acquisition cost of intraoperative imaging systems and the need for specialized operating room infrastructure limit adoption, particularly among small and mid-sized hospitals. Installation often requires structural modifications, radiation shielding, and dedicated surgical suites, increasing the total cost of ownership. These financial and infrastructure challenges delay procurement decisions and restrict market growth, especially in emerging healthcare markets.
Limited reimbursement for intraoperative imaging technologies across many healthcare systems restrains market growth by reducing financial incentives for hospitals to adopt these advanced platforms. Payment models such as Medicare Severity Diagnosis Related Groups in the US, Healthcare Resource Groups in England, and Diagnosis Related Group based reimbursement systems in several European countries primarily reimburse the surgical procedure rather than the additional value provided by intraoperative imaging.
Development of Intraoperative Molecular and Fluorescence Imaging and Growing Integration into Ambulatory Surgical Centers Open New Avenues for Market Players
The integration of molecular and fluorescence guided imaging with intraoperative imaging platforms presents a significant growth opportunity by enabling surgeons to visualize tumors, blood vessels, and critical anatomical structures beyond conventional anatomical imaging. This is expanding the role of intraoperative imaging in precision oncology and complex surgical interventions. For example, 5-aminolevulinic acid (5-ALA) fluorescence guided surgery is increasingly used during high grade glioma resections, allowing surgeons to distinguish malignant tissue from healthy brain tissue in real time and improve the extent of tumor removal while preserving critical neurological function.
The growing complexity of procedures performed in ambulatory surgical centers is creating opportunities for compact and cost-efficient intraoperative imaging systems. Manufacturers are developing mobile CT, C-arm, and 3D imaging platforms tailored for space constrained surgical environments, enabling advanced image-guided procedures outside tertiary hospitals. As outpatient spine, orthopedic, and pain management surgeries continue to increase, demand for flexible intraoperative imaging solutions is expected to accelerate across the ASC segment.
Diverse Surgical Workflows and Strict Safety Requirements Challenges Market Growth
A major challenge for the intraoperative imaging market is ensuring seamless compatibility with diverse surgical workflows, navigation systems, robotic platforms, and hospital IT infrastructure. Variations in operating room layouts, software architectures, and equipment vendors often complicate system integration and increase implementation time. These interoperability challenges can delay technology adoption and reduce operational efficiency, particularly in multi-specialty hospitals using equipment from different manufacturers.
Maintaining high-quality intraoperative imaging without disrupting surgical workflow remains a significant challenge for healthcare providers. Advanced imaging procedures can increase operating room occupancy, require repeated patient positioning, and demand strict radiation safety or sterility protocols depending on the modality used. Healthcare facilities must carefully balance image quality, procedural efficiency, and patient safety, making workflow optimization and staff coordination critical for successful intraoperative imaging utilization.
The mobile C-arms segment is expected to grow at a CAGR of 31.27% during the forecast period, owing to increasing deployment in outpatient and emergency surgical settings and expanding use in trauma, orthopedic, and pain management procedures. Their portability enables rapid intraoperative visualization without dedicated imaging suites, supporting procedural flexibility.
The iMRI segment is expected to grow at a CAGR of around 7.28% during the forecast period due to rising adoption in complex brain tumor resections and growing investments in dedicated neurosurgical imaging suites. Real-time soft tissue visualization enhances surgical precision while reducing repeat operations for intricate cranial procedures.
By application, the neurosurgery segment accounted for a share of 32.03%, owing to the need for continuous visualization of delicate brain structures, increasing utilization of brain mapping, and growing demand for maximal tumor resection. Intraoperative imaging supports immediate surgical decisions while preserving critical neurological functions.
The orthopedic surgery segment is expected to grow at a CAGR of 7.59% during the forecast period, driven by increasing demand for accurate implant alignment, rising adoption of minimally invasive joint reconstruction, and expanding volume of spinal fixation procedures. Real-time imaging improves hardware positioning accuracy and supports better postoperative functional outcomes.
By end use, hospitals accounted for a share of 38.90% in 2025 due to availability of intraoperative MRI and CT suites, increasing performance of surgeries, and centralized capital budgeting that supports procurement of high-value imaging assets. These advantages position hospitals as the primary users of fixed intraoperative imaging platforms.
The ambulatory surgical centers segment is expected to grow at a CAGR of 7.84% during the forecast period, driven by increasing preference for imaging systems, greater reliance on shared mobile imaging assets across multiple operating rooms, and expanding physician-owned specialty surgical centers. These operational requirements are accelerating adoption of compact intraoperative imaging technologies in outpatient settings.
North America: Market Dominance Led by Advanced Hybrid Surgical Infrastructure and Strong Adoption of Precision Guided Surgery
The North America intraoperative imaging market accounted for the largest regional share of 35.11% in 2025, driven by early adoption of hybrid operating rooms, widespread use of precision-guided surgical techniques, and continuous investment in advanced surgical technologies across tertiary care centers. Favorable reimbursement for complex procedures and strong healthcare capital expenditures further support market expansion.
The US intraoperative imaging market was valued at USD 1.14 billion in 2025, driven by increasing integration of intraoperative imaging into academic medical centers, rising adoption of image-guided neurosurgical and spine procedures, and continuous modernization of hybrid operating rooms. Growing demand for precision-driven interventions and advanced surgical navigation continues to strengthen market expansion. According to the United Network for Organ Sharing, the US performed 48,149 organ transplants in 2025, increasing demand for advanced intraoperative imaging to support complex liver, kidney, heart, and multi-organ transplant procedures requiring real-time anatomical visualization.
The intraoperative imaging market in Canada was valued at USD 170.20 million in 2025, supported by increasing provincial investments in integrated surgical modernization programs, expanding adoption of centralized image-guided care pathways within publicly funded healthcare systems, and growing utilization of intraoperative imaging in specialized neuroscience and musculoskeletal referral centers. The market also benefits from Canada's hub-and-spoke healthcare delivery model, where advanced surgical technologies are concentrated in regional centers to improve access to complex procedures while optimizing utilization of high-value imaging infrastructure.
Asia Pacific: Fastest Growth Driven by Increasing Availability of Specialized Cardiovascular Surgery Centers and Adoption of Advanced Imaging Technologies
The Asia Pacific intraoperative imaging market is expected to grow at a CAGR of 8.44% during the forecast period, showcasing the fastest regional growth. Growth is supported by rapid expansion of tertiary care hospitals, increasing availability of specialized cardiovascular surgery centers, and greater emphasis on reducing dependence on imported blood products. Healthcare systems are investing in advanced surgical capabilities and perioperative blood management. According to Japan’s Ministry of Health, Labour and Welfare, more than 70,000 cardiac surgeries are performed annually in Japan, reflecting the region’s substantial surgical demand base.
The China intraoperative imaging market was valued at USD 206.18 million in 2025, supported by the expansion of national and regional medical centers, increasing integration of AI-enabled surgical platforms within public hospitals, and growing domestic manufacturing of premium diagnostic imaging equipment. These initiatives are improving access to advanced surgical technologies while supporting the country's long-term objective of strengthening high-end medical device self-sufficiency.
The India intraoperative imaging market size was valued at USD 105.46 million in 2025, fueled by the emergence of dedicated neuro-spine centers of excellence, increasing adoption of advanced imaging technologies within corporate hospital chains, and growing medical tourism for complex neurosurgical and orthopedic procedures. Rising investments in integrated operating room infrastructure across private healthcare networks are further accelerating demand for intraoperative imaging solutions throughout the country.
The Japan intraoperative imaging market was valued at USD 121.68 million in 2025, supported by adoption of precision neurosurgery, integration of advanced imaging into functional brain procedures, and strong emphasis on technology-assisted surgical planning. According to Japan's Ministry of Health, Labour and Welfare, more than 70,000 cardiac surgeries are performed annually in the country, creating sustained demand for intraoperative imaging systems that enable real-time visualization and improve procedural accuracy during complex cardiovascular interventions.
The intraoperative imaging market competitive landscape is moderately consolidated, with competition led by established medical imaging and surgical technology companies offering advanced intraoperative MRI, CT, ultrasound, C-arm, and navigation solutions. Market participants compete through technological innovation, AI-enabled imaging, integrated surgical workflows, image quality, and comprehensive service capabilities. The intraoperative imaging market ecosystem is shaped by increasing adoption of image-guided surgery, expansion of hybrid operating rooms, advancements in surgical navigation, stringent regulatory requirements, and growing demand for precision-driven technologies that improve surgical accuracy, clinical outcomes, and operating room efficiency across multiple specialties.
November 2025: GE HealthCare announced the acquisition of Intelerad Medical Systems for USD 2.3 billion, expanding its enterprise imaging software and AI-enabled imaging capabilities to strengthen its connected imaging ecosystem.
September 2025: Canon Medical Systems announced the European launch of Alphenix 4D CT integrated with Aquilion ONE/INSIGHT Edition, introducing a next-generation Angio CT solution that combines CT and angiography in a single interventional suite for advanced image-guided procedures.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanashri Bhapakar is a Senior Research Associate with 3+ years of experience in the Biotechnology sector. She focuses on tracking innovation trends, R&D breakthroughs, and market opportunities within biopharmaceuticals and life sciences. Dhanashri’s deep industry knowledge enables her to provide precise, data-backed insights that help companies innovate and compete effectively in global biotech markets.
We are featured on:
sales@straitsresearch.com